Approximately 98,016 bottles of Montelukast Sodium 10 mg tablets (the generic version of Singulair) are being recalled because some bottles labeled as having 30 tablets of Montelukast may actually contain 90 tablets of Losartan Potassium 50 mg. This mix-up occurred in a single lot of medication manufactured by Hetero Labs Limited and distributed for Camber Pharmaceuticals. Consumers may inadvertently take a blood pressure medication instead of their intended asthma or allergy treatment.
Taking Losartan Potassium when it is not prescribed, especially at an incorrect dose, can cause dangerously low blood pressure or serious adverse reactions. Additionally, missing a scheduled dose of Montelukast could lead to a worsening of asthma or allergy symptoms.
Contact healthcare provider and return product for refund.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.